GD
56
3
OKE
80
2
PLD
50
7
EOG
58
9
UPS
45
-3
PFE
21
-2
EMC
65
-12
XYL
41
4
CTSH
65
2
PG
48
7
TROW
54
-8
JBHT
68
3
LYB
41
-2
CPB
24
2
HPE
70
17
STZ
50
2
NTRS
57
-2
FMC
41
-3
MSI
81
9
WEC
53
8
GD
56
3
OKE
80
2
PLD
50
7
EOG
58
9
UPS
45
-3
PFE
21
-2
EMC
65
-12
XYL
41
4
CTSH
65
2
PG
48
7
TROW
54
-8
JBHT
68
3
LYB
41
-2
CPB
24
2
HPE
70
17
STZ
50
2
NTRS
57
-2
FMC
41
-3
MSI
81
9
WEC
53
8
Financhill
Back

Avidity Biosciences 10K Form

Sell
39

RNA
Avidity Biosciences

Last Price:
46.69
Seasonality Move:
33.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RNA News And Ratings

See the #1 stock for the next 7 days that we like better than RNA

RNA Financial Statistics

Sales & Book Value

Annual Sales: $9.56M
Cash Flow: $-65.54M
Price / Cash Flow: 0
Annual Sales: $11.17
Price / Book: 4.48

Profitability

EPS (TTM): -2.95000
Net Income (TTM): $-252.45M
Gross Margin: $8.9M
Return on Equity: -34.78%
Return on Assets: -30.7%

Avidity Biosciences Earnings Forecast

Key Avidity Biosciences Financial Ratios

  • The Gross Profit Margin over the past 1 years for RNA is 100.00%.
  • The Selling, General & Administrative Expenses for RNA have been equal to 566.84% of Gross Profit Margin.
  • The Research & Development expenses have been 1,997.57% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of RNA is -2,219.87% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 1 years.

Avidity Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: RNA
CUSIP: 05370A
Website: aviditybiosciences.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 15.78
Quick Ratio: 15.61

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RNA Technical Analysis vs Fundamental Analysis

Sell
39
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy or a Sell?